XML 27 R16.htm IDEA: XBRL DOCUMENT v3.23.2
Stock-Based Compensation
6 Months Ended
Jul. 01, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation

8. Stock-Based Compensation

Stock Options

A summary of activity under Nucor’s stock option plans for the first six months of 2023 is as follows (shares and aggregate intrinsic value in thousands):

 

 

 

 

 

 

Weighted-

 

 

Weighted-

 

 

 

 

 

 

 

 

Average

 

 

Average

 

Aggregate

 

 

 

 

 

 

Exercise

 

 

Remaining

 

Intrinsic

 

 

 

Shares

 

 

Price

 

 

Contractual Life

 

Value

 

Number of shares under stock options:

 

 

 

 

 

 

 

 

 

 

 

Outstanding at beginning of year

 

 

837

 

 

$

66.76

 

 

 

 

 

 

Granted

 

 

91

 

 

$

133.03

 

 

 

 

 

 

Exercised

 

 

(131

)

 

$

54.49

 

 

 

 

$

15,539

 

Canceled

 

 

-

 

 

$

-

 

 

 

 

 

 

Outstanding at July 1, 2023

 

 

797

 

 

$

76.32

 

 

7.5 years

 

$

69,890

 

Stock options exercisable at July 1, 2023

 

 

512

 

 

$

49.84

 

 

6.7 years

 

$

58,494

 

 

For the 2023 stock option grant, the grant date fair value of $49.62 per share was calculated using the Black-Scholes options pricing model with the following assumptions:

 

Exercise price

 

$

133.03

 

Expected dividend yield

 

 

1.53

%

Expected stock price volatility

 

 

37.55

%

Risk-free interest rate

 

 

3.66

%

Expected life (in years)

 

 

6.5

 

 

Compensation expense for stock options was $3.4 million and $3.9 million in the second quarter of 2023 and 2022, respectively, and $3.9 million and $4.4 million in the first six months of 2023 and 2022, respectively. As of July 1, 2023, unrecognized compensation expense related to stock options was $2.8 million, which we expect to recognize over a weighted-average period of 2.2 years.

Restricted Stock Units

A summary of Nucor’s restricted stock unit (“RSU”) activity for the first six months of 2023 is as follows (shares in thousands):

 

 

 

Shares

 

 

Grant Date
Fair Value
Per Share

 

Restricted stock units:

 

 

 

 

 

 

Unvested at beginning of year

 

 

1,003

 

 

$

98.66

 

Granted

 

 

831

 

 

$

133.03

 

Vested

 

 

(863

)

 

$

102.49

 

Canceled

 

 

(10

)

 

$

96.92

 

Unvested at July 1, 2023

 

 

961

 

 

$

124.96

 

 

Compensation expense for RSUs was $48.5 million and $41.9 million in the second quarter of 2023 and 2022, respectively, and $60.7 million and $50.9 million in the first six months of 2023 and 2022, respectively. As of July 1, 2023, unrecognized compensation expense related to unvested RSUs was $111.9 million, which we expect to recognize over a weighted-average period of 1.8 years.

Restricted Stock Awards

A summary of Nucor’s restricted stock activity under the Nucor Corporation Senior Officers Annual Incentive Plan (a supplement to the Nucor Corporation 2014 Omnibus Incentive Compensation Plan, the “AIP”) and the Nucor Corporation Senior Officers Long-Term Incentive Plan (a supplement to the Nucor Corporation 2014 Omnibus Incentive Compensation Plan, the “LTIP”) for the first six months of 2023 is as follows (shares in thousands):

 

 

 

 

 

Grant Date

 

 

 

Shares

 

 

Fair Value
Per Share

 

Restricted stock units and restricted stock awards:

 

 

 

 

 

 

Unvested at beginning of year

 

 

209

 

 

$

108.55

 

Granted

 

 

414

 

 

$

171.38

 

Vested

 

 

(406

)

 

$

152.68

 

Canceled

 

 

(7

)

 

$

171.38

 

Unvested at July 1, 2023

 

 

210

 

 

$

144.98

 

 

Compensation expense for common stock and common stock units awarded under the AIP and the LTIP is recorded over the performance measurement and vesting periods based on the anticipated number and market value of shares of common stock and common stock units to be awarded. Compensation expense for anticipated awards based upon Nucor’s financial performance, exclusive of amounts payable in cash, was $11.7 million and $1.8 million in the second quarter of 2023 and 2022, respectively, and $19.4 million and $18.8 million in the first six months of 2023 and 2022, respectively. As of July 1, 2023, unrecognized compensation expense related to unvested restricted stock awards was $10.7 million, which we expect to recognize over a weighted-average period of 2.0 years.